Results 71 to 80 of about 17,529,802 (251)

Atom‐Efficient Cerium‐Based Molecular Cages as Biocompatible Reactive Oxygen Scavengers

open access: yesAdvanced Healthcare Materials, EarlyView.
Discrete mixed‐valent cerium molecular cages organize accessible redox centers within confined coordination environments and scavenge superoxide, hydrogen peroxide, and hydroxyl radicals. Encapsulation of the lead cage in an ROS‐responsive DTP nanoplatform enables lesion‐associated delivery, attenuates macrophage oxidative stress and inflammation, and ...
Chao Li   +9 more
wiley   +1 more source

Hemocompatible Glycogen‐Tissue Plasminogen Activator Complexes for Enhanced Blood Clot Dissolution

open access: yesAdvanced Healthcare Materials, EarlyView.
Glycogen–heparin‐cRGD nanoparticles enable targeted delivery of tissue plasminogen activator (tPA) to thrombi through activated platelet recognition. The hemocompatible hybrids minimize interactions with blood and immune cells while retaining enzymatic biodegradability.
Nadiia Davydiuk   +6 more
wiley   +1 more source

High-density lipoprotein functionality in systemic lupus erythematosus

open access: yes, 2020
High-density lipoprotein functionality in systemic lupus ...
Shiva Ganjali (14682088)   +3 more
core  

Forest plot for high-density lipoprotein.

open access: yes, 2020
Forest plot for high-density lipoprotein.
Bo Chen (32294)   +4 more
core   +1 more source

Median statistics for the ratio of triglycerides to very low-density lipoprotein cholesterol by the cross table of non-high-density lipoprotein cholesterol and triglycerides calculated from the Turkish population (calculated for each direct assay method for 180-cell strata).

open access: yes, 2022
Median statistics for the ratio of triglycerides to very low-density lipoprotein cholesterol by the cross table of non-high-density lipoprotein cholesterol and triglycerides calculated from the Turkish population (calculated for each direct assay method ...
Gökmen Zararsız (4385767)   +6 more
core   +1 more source

Effect of Poloxamer 407 on serum VLDL, LDL and HDL levels of rabbits

open access: yesNational Journal of Physiology, Pharmacy and Pharmacology, 2014
Background: Poloxamer 407 is used in parenteral formulations as solubilizing and wetting agent for traditional, low-molecular-weight organic drug molecules and as stabilizing agent for proteins and polypeptide drugs.
Harish Govind Naik   +5 more
doaj   +1 more source

Metal Compound‐Based Non‐Enzymatic Electrochemical Cholesterol Sensors: Emerging Materials and Mechanistic Insights

open access: yesAdvanced Materials Interfaces, EarlyView.
This review discusses recent progress in metal complex‐based, non‐enzymatic electrochemical sensors for cholesterol detection. We examine metal oxides, metal sulfides, and hybrid nanomaterials, highlighting their catalytic mechanisms and material design strategies.
Longfei (Jack) Yin   +6 more
wiley   +1 more source

Mechanisms of dysregulation of low-density lipoprotein receptor expression in vascular smooth muscle cells by inflammatory cytokines [PDF]

open access: yes, 2006
Objective - Although inflammation is a recognized feature of atherosclerosis, the impact of inflammation on cellular cholesterol homeostasis is unclear.
Moorhead, JF   +6 more
core  

Lipoprotein separation in a novel iodixanol density gradient, for composition, density, and phenotype analysis

open access: yesJournal of Lipid Research, 2008
Separation of lipoproteins by traditional sequential salt density floatation is a prolonged process (∼72 h) with variable recovery, whereas iodixanol-based, self-generating density gradients provide a rapid (∼4 h) alternative.
Michael S. Yee   +6 more
doaj   +1 more source

Rab1A Promotes Hepatic Steatosis by Suppressing Mitophagy via the Raf‐1/ERK1/2/PINK1 Signaling Axis

open access: yesAdvanced Science, EarlyView.
Why does fat accumulate in the liver? Our study reveals Rab1A as the molecular switch that silences the cell's mitochondrial cleanup crew. Turning Rab1A off reactivates mitophagy, clears excess fat, and reverses fatty liver disease in mice—offering a promising new therapeutic target for MASLD, a growing global health challenge.
Li Zhang   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy